PZ Cormay S.A.

CRM

PLCMRAY00029

Medical Equipment, Supplies & Distribution

Market Closed - Warsaw S.E. Other stock markets 09:25:52 17/05/2024 pm IST			5-day change	1st Jan Change
0.62 ^PLN	-1.59%		0.00%	+5.44%

2023	PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	PZ Cormay S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Cormay Seeks To Divest

December 16, 2017 at 10:30 am IST

PZ Cormay S.A. (WSE:CRM) wants to sell its shares in DIESSE Diagnostica Senese S.p.A. worth approximately PLN 41.5 millon.

Latest news about PZ Cormay S.A.

PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	10/11	CI
PZ Cormay S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	15/23/15	CI
PZ Cormay S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19	CI
PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	10/22/10	CI
PZ Cormay S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	09/22/09	CI
PZ Cormay S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	20/22/20	CI
PZ Cormay S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	22/22/22	CI
PZ Cormay S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	10/21/10	CI
Pz Cormay S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021	10/21/10	CI
Pz Cormay S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	23/21/23	CI
PZ Cormay S.A. acquired unknown minority stake in Orphée SA for CHF 1.2 million.	17/20/17	CI
Pz Cormay S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2020	06/20/06	CI
PZ Cormay S.A. completed the acquisition of 0.54% stake in Orphée SA for PLN 0.37 million.	06/20/06	CI
PZ Cormay S.A. made a tender offer to acquire remaining 2.9% stake in Orphée SA for PLN 2 million.	11/19/11	CI
PZ Cormay S.A. agreed to acquire remaining 11.6% stake in Orphée SA for PLN 7.8 million.	05/19/05	CI
PZ Cormay S.A. announced that it has received PLN 7 million in funding	11/18/11	CI
PZ Cormay S.A. announced that it expects to receive PLN 7 million in funding	07/18/07	CI
Cormay Seeks To Divest	16/17/16	CI
PZ Cormay S.A. cancelled the acquisition of an additional 12.95% stake in Orphée SA from TTL 1 SP Z O O.	18/17/18	CI
Wesolowski To Reportedly Acquire PZ Cormay	24/16/24	CI
PZ Cormay S.A. signed an agreement to acquire additional 12.95% stake in Orphée SA from TTL 1 SP Z O O for PLN 10 million.	18/16/18	CI
PZ Cormay S.A. announced that it has received funding from Ipopema Towarzystwo Funduszy Inwestycyjnych S.A..	29/15/29	CI
TTL 1 SP Z O O and another shareholder completed the acquisition of 27% stake in Orphée SA from PZ Cormay S.A..	04/15/04	CI
TTL 1 SP Z O O and another shareholder agreed to acquire 27% stake in Orphée SA from PZ Cormay S.A. for PLN 20.8 million.	26/15/26	CI
TTL 1 SP Z O O acquired 3.92% stake in PZ Cormay S.A..	22/14/22	CI

PZ Cormay SA is a Polish-based producer and wholesaler of diagnostic reagents and a distributor of the laboratory equipment. The Company is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. It offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Diagnostic & Testing Substances

	1st Jan change	Capi.
PZ CORMAY S.A.	+5.44%	13.54M
BIOMÉRIEUX	-4.67%	12.33B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5.19%	8.14B
LANTHEUS HOLDINGS, INC.	+28.50%	5.62B
AUTOBIO DIAGNOSTICS CO., LTD.	-8.09%	4.24B
10X GENOMICS, INC.	-55.31%	3.06B
ANDON HEALTH CO., LTD.	+13.49%	2.76B
VITROLIFE AB	-1.34%	2.41B
MYRIAD GENETICS, INC.	+32.24%	2.23B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-3.55%	1.87B

Diagnostic & Testing Substances

PZ Cormay S.A.

Equities

CRM

PLCMRAY00029

Medical Equipment, Supplies & Distribution

Cormay Seeks To Divest

Latest news about PZ Cormay S.A.

Chart PZ Cormay S.A.

Company Profile

Income Statement Evolution

Sector Diagnostic & Testing Substances